Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -28.66% |
| 2023 | 36.14% |
| 2022 | -1.63% |
| 2021 | 106.83% |
| 2020 | 121.18% |
| 2019 | 102.88% |
| 2018 | 0.00% |